UBS Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,000
Closed -$486K 8573
2019
Q4
$486K Buy
+10,000
New +$455K ﹤0.01% 4861

Other funds holding CSII

UBS Group's CSII Position: Q2 2023 in Review

UBS Group sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 297,393 shares — an estimated $5.91M sold.

UBS Group first reported a position in CSII in Q4 2014 and held it in 34 quarters. The position peaked at $5.91M in Q1 2023. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • UBS Group reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 297,393 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $5.91M.
  • UBS Group first reported a position in Cardiovascular Systems, Inc. in Q4 2014 and held it in 34 quarters.
  • UBS Group's Cardiovascular Systems, Inc. position peaked at $5.91M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.